The American College of Radiology (ACR) applauded members of the House Ways and Means Committee for standing against planned cuts to Medicare reimbursement for low-dose computed tomography (LDCT) lung cancer screening. According to the ACR, this exam is the first and only cost-effective test proven to significantly reduce lung cancer deaths.

September 13, 2016 — Are You Dense Inc., in collaboration with Madre Latina Inc., recently announced a new set of ...

A new study by a University of California Los Angeles (UCLA) researcher has found that a genomic test widely used to help determine whether women with a common form of breast cancer should undergo radiation is not cost effective. The study was conducted by Ann C. Raldow, M.D., assistant professor in residence in the Department of Radiation Oncology at UCLA and member of the UCLA Jonsson Comprehensive Cancer Center, in collaboration with colleagues at Harvard and University of Texas Southwestern.

September 12, 2016 — Tiny microbubbles are being used to more effectively identify liver tumors, according to a study ...

National Cancer Institute (NCI) Acting Director Douglas Lowy, M.D., accepted the recommendations of a Blue Ribbon Panel (BRP) on 10 scientific approaches most likely to make a decade’s worth of progress against cancer in five years under the Cancer Moonshot.

September 9, 2016 — Radiologists and medical imaging business managers will gain practical management skills to align ...